Artículos Científicos en Ingles

Artículos Científicos RSS AJKD

G-492 Prognostic Blood and Urine Biomarkers for Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Este artículo no posee resumen

G-485 Obinutuzumab: A Novel Therapy for Rituximab Refractory ANCA vasculitis

Este artículo no posee resumen

G-487 Unraveling the Complexity: A Case of Systemic Lupus Erythematosus (SLE) with Nephrotic Syndrome and Renal Vein Thrombosis in a 28-Year-Old Female with Latent Tuberculosis Infection

Este artículo no posee resumen

G-488 ARPKD Organoids Demonstrate that PTHR1 Agonism Induces a Cystogenic AC-pPKA-pCREB Axis

Este artículo no posee resumen

G-489 Whole Exome Sequencing Improve Diagnostic Yield in Kidney Diseases Following Negative or Inconclusive Multigene Panel Testing

Este artículo no posee resumen

G-486 Complex Acute Kidney Injury in Cirrhosis due to Hepatitis C Virus-Associated Proliferative Glomerulonephritis and Oxalate Tubulopathy Managed Post-Liver Transplantation

Este artículo no posee resumen

G-477 Living with IgA Nephropathy: A Focus Group Study on the Patient Experience

Este artículo no posee resumen

G-490 Variant of Uncertain Significance Becomes Significant: Dent Disease Type 1

Este artículo no posee resumen

G-491 Association of SGLT2i therapy with longitudinal eGFR changes among US veterans with ADPKD

Este artículo no posee resumen

G-499 Contemporary Trends in Peritoneal Dialysis Outcomes in the United States

Este artículo no posee resumen

G-393 Health Related Social Needs and Transplant Access

Este artículo no posee resumen

G-381 A Comparative Analysis of Uremic and Non-uremic Calciphylaxis

Este artículo no posee resumen

G-380 Prevalence of Gastrointestinal Complaints and Impact on Quality of Life in Inner-City Patients with End Stage Kidney Disease (ESKD)

Este artículo no posee resumen

G-379 Seeing the Unseen: Visual Hallucinations due to Inappropriate Histamine Type 2 Blocker Dose in ESRD

Este artículo no posee resumen

G-378 Patient Baseline Characteristics in the Ongoing Phase 3 VISIONARY Trial: A Randomized, Placebo-Controlled Study of Sibeprenlimab for Immunoglobulin A Nephropathy

Este artículo no posee resumen

Páginas